Skip to content

Post-op Pain After Fistula Laser Closure or Ligation of the Intersphincteric Tract for Anal Fistula

Comparison of Post-operative Pain Between Fistula Laser Closure and Ligation of the Intersphincteric Tract in the Treatment of Anal Fistula - a Randomized Controlled Trial. (LASERLIFT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212739
Acronym
LASERLIFT
Enrollment
56
Registered
2024-01-19
Start date
2018-01-01
Completion date
2021-08-02
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fistula in Ano

Brief summary

This is a prospective, double-blinded randomised controlled trial conducted at two tertiary hospitals by a credentialed colorectal surgeon.

Detailed description

Patients with high transphincteric fistulas were blinded and randomized to either laser or ligation of the fistula tract (LIFT). Pain scores at rest and movement, at 6 and 24 hours post operatively were measured using the visual analogue scale (VAS). Operative time was measured in minutes Continence and quality of life was assessed via the Wexner incontinence scale and SF-36 questionnaire respectively at 0, 3 and 6 months post-operatively.

Interventions

PROCEDURELaser

Diode laser used to effect closure of the anal fistula tract

PROCEDURELIFT

The intersphincteric portion of the fistula is excised and ligated.

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcomes assessor was blinded to the intervention.

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Complex transphincteric fistulas: * high transphincteric fistula, involving more than 30% of the external anal sphincter * Multiple fistulas * Anterior fistulas * 18-75 years old * Able to give consent * New or recurrent fistulas * Fistulas with or without setons

Exclusion criteria

* Active perianal sepsis requiring drainage * Fistulas of non-cryptogladular origin- Crohn's, TB, malignancy * Expected lifespan less than 6 months * Pregnant women * Patients with more than 1 definitive surgery done for the fistula before * Patients with human immunodeficiency virus infection * Patients with pre-existing chronic pain disorders * Patients with Non-steroidal Anti-inflammatory Drug (NSAIDS) / Paracetamol allergies

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain score6 hours, 24 hoursPost-operative pain will be assessed by a blinded assessor using the Visual Analogue Scale (VAS), a validated pain score.

Secondary

MeasureTime frameDescription
ContinenceAt baseline, and at 1 week, 1 month and 6 months post-operativelyThe Wexner score was used to assess pre- and post-operative continence. Minimum score is 3, maximum score is 12. The lower the score, the worse the incontinence.
SF36At baseline, and at 1 week, 1 month and 6 months post-operativelyThe SF36 was used to assess pre- and post-operative quality of life.
Operative timeIntraoperativeMedian operative time was to compare the two arms
Duration of analgesia useNumber of days until cessation of analgesia use, assessed at 1 week or 1 month, whichever is shorterThe duration in days that the patient needed to use analgesia post-operative
Failure rate6 monthsFailure to heal was defined as failure of fistula closure (persistent discharge) beyond 6 months' post-operatively
Return to workNumber of days taken to return to work, assessed at 6 months post-operativelyDays until return to work

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026